Sedana Medical AB (FRA:7D2A)
€ 1.066 0.054 (5.34%) Market Cap: 110.49 Mil Enterprise Value: 91.51 Mil PE Ratio: 0 PB Ratio: 1.15 GF Score: 65/100

Sedana Medical AB (publ) at Redeye Medtech Seminar (Virtual) Transcript

Oct 26, 2022 / 09:20AM GMT
Release Date Price: €1.81 (-17.91%)
Oscar Bergman
Redeye AB, Research Division - Analyst

We have 3 more presenting companies here at Redeye Medtech Day. First up, Sedana Medical with CEO, Johannes Doll. Welcome.

Johannes Doll;publ;CEO;President
Sedana Medical AB

()-&

Thank you, Oscar, for this kind introduction. Thanks to all of you for taking the time of watching this short company presentation of Sedana Medical.

So who are we? Sedana Medical exists in order to improve life during and beyond sedation. That's our purpose. And in order to live up to that purpose, our roughly 100 colleagues, including myself, get up every morning and work very hard on making inhaled sedation the standard of care in intensive care units. And of course, I will get much more into what that means and how that works. But if you're in medical devices, it's always a good place to start, whose lives are you making better?.

And in our case, those are mechanically ventilated patients in intensive care units. If you look at the world, roughly 30 million

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot